胎儿骨骼系统超声异常时的扩展基因检测
该前瞻性观察队列研究纳入55例超声发现骨骼系统异常的胎儿,先行CMA及多倍体检测,结果正常或与表型不符者再行外显子测序。染色体异常检出率43.6%,ES在26例中18例阳性,总遗传学异常检出率达76.4%。结论认为骨骼异常胎儿应在常规检测后行扩展基因检测。
要点
- 超声发现胎儿骨骼异常时,染色体异常是最常见遗传诊断,检出率43.6%。
- CMA正常或与表型不符者应进一步行外显子测序,可额外提高诊断率32.7%。
- 扩展基因检测可使骨骼异常胎儿总体遗传学异常检出率达到76.4%。
核心结论
- 胎儿骨骼系统异常中染色体异常是最常见遗传诊断,外显子测序可在CMA和多倍体检测基础上进一步提高诊断率。
- 骨骼异常胎儿应在常规遗传检测后接受扩展基因检测,以避免漏诊可导致骨骼缺陷的遗传异常。
研究设计与样本
- 前瞻性观察队列研究,纳入单中心超声部门1年(2019年)内所有单胎妊娠且超声发现骨骼系统异常的胎儿,共55例。
- 所有胎儿行染色体微阵列分析(CMA)并补充多倍体检测,结果正常或异常与表型不符者行外显子测序(ES)。
- 变异由专家组讨论判读,以识别致病/可能致病变异。
诊断标准与关键数值
- CMA及多倍体检测检出与表型一致的染色体异常24/55例(43.6%)。
- 排除后26例(47.3%)行ES,其中18例(69.2%)ES结果异常,额外提高诊断率18例(32.7%)。
- 总体遗传学检测异常为42/55例(76.4%)。
- 18例胎儿中检出14个不同基因的致病或可能致病序列变异,其中7个基因已列入国际骨骼发育不良学会Nosology,7个未列入。
临床应用与阅片要点
- 超声发现胎儿骨骼系统异常时,应将遗传学评估纳入诊断路径,常规CMA及多倍体检测后考虑外显子测序。
- 判读基因结果时注意部分致病基因未列入国际骨骼发育不良学会Nosology,不能仅依据Nosology列表排除相关基因。
局限性
- 单中心研究,样本量55例,研究周期为1年。
- ES仅对CMA结果正常或与表型不符的26例进行,非全部胎儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To analyze genetic causes of skeletal system abnormalities diagnosed by prenatal sonography and to establish a diagnostic protocol with regard to extended genetic testing in this group of patients.
METHODS: This prospective observational cohort study included all singleton pregnancies with a sonographic abnormality of the skeletal system evaluated in a single ultrasound department during a 1-year period (2019). Fetuses underwent routine genetic testing by chromosomal microarray analysis (CMA) supplemented with polyploidy testing, and those with either a normal result or an abnormal result not consistent with the observed phenotype underwent exome sequencing (ES). Interpretation of variants was discussed by a panel of specialists to identify pathogenic/likely pathogenic variants.
RESULTS: The study group comprised 55 fetuses. A chromosomal abnormality consistent with the observed phenotype was detected in 24 (43.6%) cases. After exclusions, 26 (47.3%) cases underwent further molecular testing by ES, of which 18 (69.2%) were classified as having abnormal ES results, thus increasing the diagnostic yield by a further 18 (32.7%) cases and giving an abnormal genetic test result in 42/55 (76.4%) fetuses overall. Pathogenic or likely pathogenic sequence variants in 14 different genes were detected across 18 fetuses. Seven genes are already listed in the International Skeletal Dysplasia Society Nosology and seven are not typically found to be causal for skeletal dysplasias and are not listed in the Nosology.
CONCLUSIONS: In fetuses with skeletal system anomalies, chromosomal abnormality was the most common genetic diagnosis. Exome sequencing increased the diagnostic yield over that of CMA and polyploidy testing. Fetuses with skeletal abnormalities should undergo extended genetic testing following routine testing, as many genetic anomalies responsible for skeletal defects may otherwise be missed. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Kucińska-Chahwan A, Roszkowski T, Nowakowska B, et al. Extended genetic testing in fetuses with sonographic skeletal system abnormalities. Ultrasound Obstet Gynecol. 2022. PMID: 34198368. doi:10.1002/uog.23722
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。